Conmed (CNMD) Tops Q3 EPS by 65c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $35.95 +4.02%
EPS Growth %: -3.5%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -3.5%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.88, $0.65 better than the analyst estimate of $0.23. Revenue for the quarter came in at $237.8 million versus the consensus estimate of $205.92 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Hyperscale Data acquires 48.5 acres to expand Michigan campus
- Argus Starts SpaceX (SPCX) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
